28 Jun Intrexon Update
XON $ 13.20 Biotech under pressure, convertible offering added more...
XON $ 13.20 Biotech under pressure, convertible offering added more...
We actually had two TPS Position reports written up earlier this week with plans to release one of them. One of the stocks literally ran up 20% while we were finishing the report and breaking out of a long base pattern, so we didnt want...
XSPL $8.50 area Huge move in XSPL earlier this morning as high as $11.70 from $7.56 close last Friday. We have been saying to buy from 6.50-7.75 inclusive, and we also said we were accumulating quite a few shares ourselves under $7 recently. The reason is besides...
Today we are doing some quick notes and charts on all 6 positions, plus notes on buy ranges. Strategy Update: Recent IPO research work coming next! Our next 2-3 TPS Positions are going to be companies that have IPO'd within the last several weeks to 9-12 months....
Today we have Chart updates on all 6 positions and some general buy range notes, see each chart for annotations: XSPL Update: In the low end of our suggested 6.50-7.75 buy ranges. We said this stock could air pocket up and down due to thin float,...
Today we are updating developments if any on the 6 open positions, we did charts and brief technical notes on Wednesday this week: CLLS- $31- Cellectis effectively has about 480 million in cash, plus a 74% stake in CLXT. CLXT has 32 million shares outstanding now after...
We are updating 6 positions for the TPS Portfolio as we work towards our goal of 12 positions. Right now we have 1/2 position on AQMS and 5 Full Positions on CLLS, EXPI, ADAP, XON, and working on XSPL. CLLS is a strong buy at 24-28 and...
Updating all 5 positions in the TPS Portfolio 1/2 Long AQMS Full Positions on CLLS, EXPI, ADAP, AQMS New TPS Report Due: Monday or Tuesday next week. We are completing a full research report on a recent IPO that is flying under the radar for several reasons which we...
EXPI 14.20 First written up at $6.44 with a $7.25 Max buy , later $8.50 EXPI just reported their 1st quarter 2018 results with revenues exploding year over year up 188% and Agent count nearly tripling. Q1 2018 Highlights $62 million in revenue, 188% increase year-over-year Nearly tripled...
Just some quick thoughts for Monday morning on our positions. XON- $14.90, down from $19.19 highs last Thursday on the reaction to the quarterly report. We find the sell off way overdone and purchased a fair amount of shares at a 15.40 average on Friday working...
indian xxnx horny desi indian cheating slime wife show boobs in webcam.